...
首页> 外文期刊>Vaccine >Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis
【24h】

Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis

机译:马来氏TRX线虫特异性保护表位的鉴定和表征,以开发用于淋巴丝虫病的合成疫苗构建体

获取原文
获取原文并翻译 | 示例
           

摘要

Although multi-epitope vaccines have been evaluated for various diseases, they have not yet been investigated for lymphatic filariasis. Here, we report for the first time identification of two immunodominant B epitopes (TRXP1 and TRXP2) from the antioxidant Brugia malayi thioredoxin by studying their immune responses in mice model and human subjects. TRXpi was also found to harbor a T epitope recognized by human PBMCs and mice splenocytes. Further, the epitopic peptides were synthesized as a single peptide conjugate (PC1) and their prophylactic efficacy was tested in a murine model of filariasis with L3 larvae. PC1 conferred a significantly high protection (75.14%) (P < 0.0001) compared to control (3.7%) and recombinant TRX (63.03%) (P < 0.018) in experimental filariasis. Our results suggest that multi-epitope vaccines could be a promising strategy in the control of lymphatic filariasis
机译:尽管已经对多表位疫苗进行了多种疾病的评估,但尚未针对淋巴丝虫病进行研究。在这里,我们通过研究小鼠模型和人类受试者的免疫应答,首次报告了来自抗氧化剂马来亚硫氧还蛋白的两个免疫优势B表位(TRXP1和TRXP2)的鉴定。还发现TRXpi具有人类PBMC和小鼠脾细胞识别的T表位。此外,表位肽被合成为单肽结合物(PC1),并且在具有L3幼虫的丝虫病的鼠模型中测试了它们的预防功效。与对照组(3.7%)和重组TRX(63.03%)(P <0.018)相比,PC1具有显着高的保护(75.14%)(P <0.0001)。我们的结果表明,多表位疫苗可能是控制淋巴丝虫病的有前途的策略

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号